Novel tools for earlier stage lung cancer detection and treatment in improving survivorship curve
(30 min) Learn how to use imaging technology to enable a diagnostic shift from late to early-stage lung cancer. With more efficient lung cancer programs,
implementing radiomics-based imaging data analysis, a new generation of intelligent tools, proven technologies like Low-Dose CT (LDCT), and CT-navigation for stereotactic needle guidance for biopsies, this panel will discuss radiologists’ ability to impact lung cancer staging today and into the future. The exchange will include evaluating patient risk, integrating radiomics, LDCT, AI and improved CT-navigation that can help radiologists as a key part of the multidisciplinary teams drive greater clinical outcomes and patient quality of life.
Speaker(s):
Stephen J. Hunt, MD, PhD, DABR, Interventional Radiologist, Co-Director, Image-Guided Interventions Laboratory Assistant Professor of Radiology at the
Hospital of the University of Pennsylvania
Dr. Raymond U. Osarogiagbon, MBBS, FACP, Chief Scientist, Baptist Memorial Healthcare Corporation, TN, Director of the
Multidisciplinary Thoracic Oncology Program and the Thoracic Oncology Research
Group, Baptist Cancer Center, and Principal Investigator of the Baptist Health
System/Mid-South Minority-Underserved Consortium NCORP
Dr. Anil Vachani, MSCE, Associate Professor of Medicine, Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center
Moderator:
Ben Newton, PhD, General Manager, Oncology Solutions, GE HealthCare